Neuroscience Research Group, Stavanger University Hospital, Postboks 8100, 4068 Stavanger, Norway.
Department of Neurology, Stavanger University Hospital, Postboks 8100, 4068 Stavanger, Norway; Neuroscience Research Group, Stavanger University Hospital, Postboks 8100, 4068 Stavanger, Norway.
J Neurol Sci. 2024 Nov 15;466:123265. doi: 10.1016/j.jns.2024.123265. Epub 2024 Oct 4.
Wake-up stroke (WUPS) patients can be selected to intravenous thrombolysis (IVT) treatment based on the Magnetic Resonance Imaging (MRI) mismatch concept. However, recent studies suggest the introduction of modified MRI mismatch criteria, allowing IVT in WUPS patients with a partial mismatch.
WUPS patients treated with IVT in the NOR-TEST trial and consecutively thereafter at Stavanger University Hospital were included in this study. Patient selection for treatment was performed based on the clinical presentation and the MRI DWI/FLAIR mismatch criteria. MRI examinations were reassessed according to the modified DWI-FLAIR mismatch criteria, allowing partial mismatch. Improvement in NIHSS and mRS at 3 months were used to analyze clinical outcome, and the rate of intracranial hemorrhage (ICH) to analyze safety.
78 WUPS patients were treated with IVT. Only 68 of these patients were independent pre-stroke and included in the clinical analysis. When reassessing the MRI examinations, 41 (60 %) were rated as DWI/ FLAIR mismatch, 14 (21 %) as partial mismatch and 13 (19 %) as match. The results show that the patient groups had a mRS score 0-1 at 3 months measured as primary outcome to respectively 27 (65.9 %), 11 (78.6 %) and 8 (61.5 %); (P = 0.629). The mismatch group showed the best clinical improvement (3-points NIHSS reduction, p = 0.005). No ICH was seen in any of the groups.
Our study extended the mismatch concept in clinical praxis to treat WUPS patients with partial mismatch, showing the best clinical outcome in the mismatch group.
根据磁共振成像(MRI)不匹配概念,可以选择醒后卒中(WUPS)患者进行静脉溶栓(IVT)治疗。然而,最近的研究表明,引入改良的 MRI 不匹配标准,可以允许 WUPS 患者存在部分不匹配的情况下进行 IVT。
本研究纳入了 NOR-TEST 试验中接受 IVT 治疗的 WUPS 患者,以及随后在斯塔万格大学医院接受治疗的连续患者。治疗患者的选择是基于临床表现和 MRI DWI/FLAIR 不匹配标准进行的。根据改良的 DWI-FLAIR 不匹配标准重新评估 MRI 检查,允许存在部分不匹配。使用 NIHSS 和 mRS 在 3 个月的改善来分析临床结局,使用颅内出血(ICH)的发生率来分析安全性。
78 例 WUPS 患者接受 IVT 治疗。只有 68 例符合独立于卒中前条件并纳入临床分析的患者。重新评估 MRI 检查时,41 例(60%)被评为 DWI/FLAIR 不匹配,14 例(21%)为部分不匹配,13 例(19%)为匹配。结果表明,3 个月时以主要结局测量的 mRS 评分 0-1 的患者组分别为 27 例(65.9%)、11 例(78.6%)和 8 例(61.5%);(P=0.629)。不匹配组显示出最佳的临床改善(NIHSS 降低 3 分,p=0.005)。在任何一组中均未观察到 ICH。
我们的研究将不匹配概念扩展到临床实践中,以治疗存在部分不匹配的 WUPS 患者,结果显示不匹配组的临床结局最佳。